Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction.
about
An ultrasound-driven kinematic model for deformation of the infarcted mouse left ventricle incorporating a near-incompressibility constraintA nonpeptide angiotensin II type 2 receptor agonist does not attenuate postmyocardial infarction left ventricular remodeling in mice.Serial ultrasound evaluation of intramyocardial strain after reperfused myocardial infarction reveals that remote zone dyssynchrony develops in concert with left ventricular remodeling.Comprehensive cardiovascular magnetic resonance of myocardial mechanics in mice using three-dimensional cine DENSE.Multimodality imaging of myocardial injury and remodeling.Improved arterial spin labeling after myocardial infarction in mice using cardiac and respiratory gated look-locker imaging with fuzzy C-means clustering.Measurement of myocardial mechanics in mice before and after infarction using multislice displacement-encoded MRI with 3D motion encoding.Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRIInteraction between AT1 and AT2 receptors during postinfarction left ventricular remodeling.High frequency ultrasound imaging detects cardiac dyssynchrony in noninfarcted regions of the murine left ventricle late after reperfused myocardial infarctionInteraction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling.Effects of cardiac overexpression of the angiotensin II type 2 receptor on remodeling and dysfunction in mice post-myocardial infarctionEffects of coronary ischemia-reperfusion in a rat model of early overnutrition. Role of angiotensin receptors.Angiotensin AT2 receptors: cardiovascular hope or hype?Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7).Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling.Chronic Losartan Treatment Up-Regulates AT1R and Increases the Heart Vulnerability to Acute Onset of Ischemia and Reperfusion Injury in Male Rats.High-resolution longitudinal MRI of the transition to heart failure.Angiotensin receptors alter myocardial infarction-induced remodeling of the guinea pig cardiac plexusCardiac magnetic resonance imaging in small rodents using clinical 1.5 T and 3.0 T scanners.Impact of AT2 receptor deficiency on postnatal cardiovascular development.INTERCOMPARISON OF PERFORMANCE OF RF COIL GEOMETRIES FOR HIGH FIELD MOUSE CARDIAC MRICardiac structure and function during ageing in energetically compromised Guanidinoacetate N-methyltransferase (GAMT)-knockout mice - a one year longitudinal MRI study.BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine.Characterization of the structural and functional changes in the myocardium following focal ischemia-reperfusion injury.Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction.Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury.Angiotensin II type-2 receptor-specific effects on the cardiovascular system.Adapter proteins and promoter regulation of the angiotensin AT2 receptor--implications for cardiac pathophysiology.The past, present and future of angiotensin II type 2 receptor stimulation.Assessment of Longitudinal Reproducibility of Mice LV Function Parameters at 11.7 T Derived from Self-Gated CINE MRI.Genetically modified mouse models used for studying the role of the AT2 receptor in cardiac hypertrophy and heart failure.Angiotensin II type 2 receptor agonists: where should they be applied?AT2 receptors targeting cardiac protection post-myocardial infarction.Anti-fibrotic Potential of AT2 Receptor AgonistsAT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation.Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synoviumThe Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate CancerEffects of the angiotensin II subtype 1 receptor antagonist losartan on functional recovery of isolated rat hearts undergoing global myocardial ischemia-reperfusion.Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes.
P2860
Q30301062-C1D1455D-D2BF-46D7-8181-00CE29066D8DQ30421609-9A8DCCAF-5B2E-4946-87EE-7C7BE2D9521FQ30426335-49042FAC-1240-41D7-AFB4-5BA02D32BBA8Q30428359-5F870F0C-1760-46E7-AC58-6B7D813B9F08Q30432655-B630FC4F-F686-4A85-B565-45E24C51A856Q30433088-F5C61B70-4391-43E8-9D05-684A3358A576Q30434968-42B88010-F1B2-48E6-BB63-3DD7BC8108FFQ30437694-38825EC8-23FD-43BC-8B02-70B940CCF9C2Q30438294-5FB1CB9F-AD3F-446D-8940-6D08208541D0Q30439344-3C8B09DF-EBA3-41B7-B5C3-635A104DF6CEQ30444722-801B3536-A687-4501-ABE2-DED985E0FCF3Q33650781-2FE381F3-18F2-4B04-B096-3DBE45DA607BQ34577046-088FFA9C-234B-4928-AA27-83D5E26C5270Q35045801-625758E2-B974-405A-AFC1-1BD600924D05Q35251166-10D26CE2-8C40-476B-8264-3DDDFCE6B936Q35608848-9C4D5D09-FD64-4530-97F1-1008D72F7DA6Q35689575-2494B67F-3267-4ACD-937D-2D86A6572440Q35787409-F4F667C6-E122-4DB1-ABF9-DACEDFB7EA4DQ35859263-7BC7B5B9-D143-42D4-A46F-B1EE74A79EE2Q36137976-E7DDC3B9-304E-467D-8AE6-449FDA01C464Q36354009-40C10393-054C-48D7-84CE-C91BFFE697C7Q36430035-32ACD1F2-39CF-44B0-9641-FA0ED0CC8780Q36478149-2A4A6BA2-0F9D-4D55-9742-179C4A6D5965Q36583396-8044F9D4-2BAE-4053-AE0C-CCB79B8FB968Q36635808-69E40994-2940-4CD7-91DA-B89A9C772334Q36675350-E2C5611D-9D4D-4C2F-B09F-EB8738E923B7Q36748599-34998C7F-8AAC-43AD-BEB9-B3343E07530EQ37339329-33738271-0B8E-4D94-9DC0-63FC77A07FEEQ37598488-75E83174-1395-4F8C-8E9B-E2EC6FFBAD16Q37622572-B245F927-9910-49C8-B51C-77BD0CF0558DQ37685676-42668C45-0AC3-41C0-B234-F7FAC950F21FQ37871869-0DBCB309-6810-4F8D-9310-587FD8EA7792Q37986143-B767541B-77C3-4602-8153-AB08F56D1B0EQ38208962-802F5097-A88D-4448-B2CC-B655A5B66D5DQ41608603-6D3EB7E5-9BAD-49F4-981A-92B61C703576Q41819451-E796B6D6-3C69-4367-8FDB-B98AC26CB01BQ42378890-5F560D58-FC98-446A-A423-D148AA91B869Q42448400-C20B01CB-924A-408F-BD3A-9DA582743787Q44657166-AD9BC4F9-1822-484F-94C9-0A4E5213AA70Q46820254-EB2E9C88-5728-4161-AE89-D8460527FC03
P2860
Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Angiotensin II type 2 receptor ...... n after myocardial infarction.
@ast
Angiotensin II type 2 receptor ...... n after myocardial infarction.
@en
type
label
Angiotensin II type 2 receptor ...... n after myocardial infarction.
@ast
Angiotensin II type 2 receptor ...... n after myocardial infarction.
@en
prefLabel
Angiotensin II type 2 receptor ...... n after myocardial infarction.
@ast
Angiotensin II type 2 receptor ...... n after myocardial infarction.
@en
P2093
P50
P1433
P1476
Angiotensin II type 2 receptor ...... n after myocardial infarction.
@en
P2093
Christina M Bove
Jennifer J Gibson
Joseph M DiMaria
Robert M Carey
P304
P356
10.1161/01.CIR.0000020014.14176.6D
P407
P577
2002-07-01T00:00:00Z